tiprankstipranks
Trending News
More News >
Parenteral Drugs (India) Limited (IN:PDPL)
:PDPL
India Market

Parenteral Drugs (India) Limited (PDPL) Ratios

Compare
0 Followers

Parenteral Drugs (India) Limited Ratios

IN:PDPL's free cash flow for Q4 2022 was ₹―. For the 2022 fiscal year, IN:PDPL's free cash flow was decreased by ₹ and operating cash flow was ₹―. See a summary of the company’s cash flow.
Ratios
TTM
Dec 22Dec 21Dec 20Dec 19
Liquidity Ratios
Current Ratio
0.06- 0.06 0.06 0.07
Quick Ratio
0.06- 0.06 0.06 0.07
Cash Ratio
<0.01- <0.01 <0.01 <0.01
Solvency Ratio
-0.03- -0.03 -0.08 -0.09
Operating Cash Flow Ratio
>-0.01- >-0.01 0.11 0.11
Short-Term Operating Cash Flow Coverage
0.00- 0.00 0.12 0.12
Net Current Asset Value
₹ -12.41B-₹ -12.41B₹ -11.83B₹ -10.46B
Leverage Ratios
Debt-to-Assets Ratio
0.22- 0.22 1.89 1.71
Debt-to-Equity Ratio
-0.13- -0.13 -1.57 -1.69
Debt-to-Capital Ratio
-0.15- -0.15 2.76 2.46
Long-Term Debt-to-Capital Ratio
-0.15- -0.15 -0.05 -0.06
Financial Leverage Ratio
-0.59- -0.59 -0.83 -0.98
Debt Service Coverage Ratio
0.35- 0.66 0.02 0.01
Interest Coverage Ratio
>-0.01- 0.00 >-0.01 >-0.01
Debt to Market Cap
10.61- 9.99 114.10 122.05
Interest Debt Per Share
71.58- 71.58 401.47 354.21
Net Debt to EBITDA
2.88- 2.88 -91.52 -65.52
Profitability Margins
Gross Profit Margin
35.67%-35.67%39.80%5.58%
EBIT Margin
-33.89%--33.89%-238.92%-132.30%
EBITDA Margin
438.65%-438.65%-96.35%-60.10%
Operating Profit Margin
-0.14%-0.00%-0.24%-0.13%
Pretax Profit Margin
-1.28%--1284.39%-1271.11%-589.95%
Net Profit Margin
-898.77%--898.77%-1001.55%-474.81%
Continuous Operations Profit Margin
-0.90%--898.77%-1001.55%-474.81%
Net Income Per EBT
69975.90%-69.98%78.79%80.48%
EBT Per EBIT
928.24%-0.00%530847.55%442488.33%
Return on Assets (ROA)
-15.77%--15.77%-21.42%-20.67%
Return on Equity (ROE)
10.13%-9.27%17.82%20.32%
Return on Capital Employed (ROCE)
<0.01%-0.00%<0.01%<0.01%
Return on Invested Capital (ROIC)
<0.01%-0.00%>-0.01%>-0.01%
Return on Tangible Assets
-15.77%--15.77%-21.80%-21.04%
Earnings Yield
-883.10%--711.39%-1295.87%-1471.48%
Efficiency Ratios
Receivables Turnover
0.92- 0.00 1.29 0.00
Payables Turnover
0.56- 0.56 0.94 2.86
Inventory Turnover
5.32- 5.32 4.60 18.07
Fixed Asset Turnover
0.04- 0.04 0.04 0.07
Asset Turnover
0.02- 0.02 0.02 0.04
Working Capital Turnover Ratio
>-0.01- >-0.01 -0.01 -0.03
Cash Conversion Cycle
-188.50- -585.70 -28.27 -107.41
Days of Sales Outstanding
397.19- 0.00 282.13 0.00
Days of Inventory Outstanding
68.61- 68.61 79.38 20.20
Days of Payables Outstanding
654.31- 654.31 389.78 127.61
Operating Cycle
465.81- 68.61 361.51 20.20
Cash Flow Ratios
Operating Cash Flow Per Share
-0.16- -0.16 42.03 37.69
Free Cash Flow Per Share
-0.16- -0.16 42.03 37.69
CapEx Per Share
0.00- 0.00 0.00 0.00
Free Cash Flow to Operating Cash Flow
1.00- 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
0.00- 0.00 0.00 0.00
Capital Expenditure Coverage Ratio
0.00- 0.00 0.00 0.00
Operating Cash Flow Coverage Ratio
>-0.01- >-0.01 0.12 0.12
Operating Cash Flow to Sales Ratio
-0.06- -0.06 10.31 4.68
Free Cash Flow Yield
-4.78%--4.50%1334.30%1449.43%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-0.11- -0.14 -0.08 -0.07
Price-to-Sales (P/S) Ratio
1.19- 1.26 0.77 0.32
Price-to-Book (P/B) Ratio
-0.01- -0.01 -0.01 -0.01
Price-to-Free Cash Flow (P/FCF) Ratio
-20.94- -22.24 0.07 0.07
Price-to-Operating Cash Flow Ratio
-17.91- -22.24 0.07 0.07
Price-to-Earnings Growth (PEG) Ratio
>-0.01- <0.01 -0.01 <0.01
Price-to-Fair Value
-0.01- -0.01 -0.01 -0.01
Enterprise Value Multiple
3.15- 3.16 -92.32 -66.06
Enterprise Value
1.17B- 1.18B 10.81B 9.54B
EV to EBITDA
3.15- 3.16 -92.32 -66.06
EV to Sales
13.81- 13.88 88.95 39.70
EV to Free Cash Flow
-243.02- -244.32 8.63 8.49
EV to Operating Cash Flow
-243.02- -244.32 8.63 8.49
Tangible Book Value Per Share
-276.32- -276.32 -228.98 -188.21
Shareholders’ Equity Per Share
-276.36- -276.36 -229.02 -188.25
Tax and Other Ratios
Effective Tax Rate
0.30- 0.30 0.21 0.20
Revenue Per Share
2.85- 2.85 4.08 8.06
Net Income Per Share
-25.61- -25.61 -40.82 -38.26
Tax Burden
699.76- 0.70 0.79 0.80
Interest Burden
0.04- 37.90 5.32 4.46
Research & Development to Revenue
0.00- 0.00 0.00 0.00
SG&A to Revenue
0.00- 0.00 0.08 0.04
Stock-Based Compensation to Revenue
0.00- 0.00 0.00 0.00
Income Quality
<0.01- <0.01 -0.81 -0.79
Currency in INR